EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Metabolomics in Acute Kidney Injury: The Clinical Perspective

Daniel Patschan, Susann Patschan, Igor Matyukhin, Oliver Ritter, Werner Dammermann iD

Journal of Clinical Medicine · 16.06.2023 · 12 (12) · 4083

DOI: 10.3390/jcm12124083 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 16.06.2023. Verfasst von Daniel Patschan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine 1, Cardiology, Angiology, Nephrology, Brandenburg Medical School Theodor Fontane, University Hospital Brandenburg, 14770 Brand…. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Brandenburg Medical School publication fund supported by the German Research Foundation and the Ministry of Science, Research and Cultural Affairs of the State….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Acute kidney injury (AKI) affects increasing numbers of hospitalized patients worldwide. The diagnosis of AKI is made too late in most individuals since it is still based on dynamic changes in serum creatinine. In recent years, new AKI biomarkers have been identified; however, none of these can reliably replace serum creatinine yet. Metabolomic profiling (metabolomics) allows the concomitant detection and quantification of large numbers of metabolites from biological specimens. The current article aims to summarize clinical studies on metabolomics in AKI diagnosis and risk prediction.

Methods

The following databases were searched for references: PubMed, Web of Science, Cochrane Library, and Scopus, and the period lasted from 1940 until 2022. The following terms were utilized: ‘AKI’ OR ‘Acute Kidney Injury’ OR ‘Acute Renal Failure’ AND ‘metabolomics’ OR ‘metabolic profiling’ OR ‘omics’ AND ‘risk’ OR ‘death’ OR ‘survival’ OR ‘dialysis’ OR ‘KRT’ OR ‘kidney replacement therapy’ OR ‘RRT’ OR ‘renal replacement therapy’ OR ‘recovery of kidney function’ OR ‘renal recovery’ OR ‘kidney recovery’ OR ‘outcome’. Studies on AKI risk prediction were only selected if metabolomic profiling allowed differentiation between subjects that fulfilled a risk category (death or KRT or recovery of kidney function) and those who did not. Experimental (animal-based) studies were not included.

Results

In total, eight studies were identified. Six studies were related to the diagnosis of AKI; two studies were performed on metabolic analysis in AKI risk (death) prediction. Metabolomics studies in AKI already helped to identify new biomarkers for AKI diagnosis. The data on metabolomics for AKI risk prediction (death, KRT, recovery of kidney function), however, are very limited.

Conclusions

Both the heterogenous etiology and the high degree of pathogenetic complexity of AKI most likely require integrated approaches such as metabolomics and/or additional types of ‘-omics’ studies to improve clinical outcomes in AKI.

Schlagwörter

Stichwörter der Autor:innen

AKIKRTmetabolomicsrecovery of kidney functionsurvival

Autor:innen und Institutionen

  • Department of Medicine 1, Cardiology, Angiology, Nephrology, Brandenburg Medical School Theodor Fontane, University Hospital Brandenburg, 14770 Brandenburg, Germany.
  • Faculty of Health Sciences Brandenburg, Brandenburg Medical School Theodor Fontane, 15562 Rüdersdorf bei Berlin, Germany.
  • Department of Medicine 2, Gastroenterology, Diabetes, Endocrinology, Brandenburg Medical School Theodor Fontane, University Hospital Brandenburg, 14770 Brandenburg, Germany.

ORCID-Profile: Werner Dammermann

Förderung

  • Brandenburg Medical School publication fund supported by the German Research Foundation and the Ministry of Science, Research and Cultural Affairs of the State…

Zitieren

APA

Patschan, D., Patschan, S., Matyukhin, I., Ritter, O., & Dammermann, W. (2023). Metabolomics in Acute Kidney Injury: The Clinical Perspective. Journal of Clinical Medicine, 12(12), 4083. https://doi.org/10.3390/jcm12124083

Vancouver

Patschan D, Patschan S, Matyukhin I, Ritter O, Dammermann W. Metabolomics in Acute Kidney Injury: The Clinical Perspective. Journal of Clinical Medicine. 2023;12(12):4083. doi:10.3390/jcm12124083

BibTeX
@article{Patschan2023,
  author = {Patschan, Daniel and Patschan, Susann and Matyukhin, Igor and Ritter, Oliver and Dammermann, Werner},
  title = {Metabolomics in Acute Kidney Injury: The Clinical Perspective},
  journal = {Journal of Clinical Medicine},
  year = {2023},
  volume = {12},
  number = {12},
  pages = {4083},
  doi = {10.3390/jcm12124083}
}
Kostenlos starten →